The American Journal of Preventive Cardiology (AJPC) announces the publication of the POLY-ACS trial investigating the effectiveness of a polypill strategy, combining multiple evidence-based therapies ...

Last week, 85 people filed into Alameda County Superior Court in downtown Oakland. They’d been called to serve as jurors for a case in which the defendant, an Oakland woman named Eboni Route, faces ...

CAHOOTS needs Council support, says team of 9- to 11-year-old Girl Scouts. Meet the girls standing up for the unhoused in ...

Over the course of nearly 300 posts, Jonathan Bennett set a very high bar for this column, so we knew it needed to be placed in the hands of somebody who could do it justice.

Dianthus Therapeutics Inc. DNTH shares are up during Monday’s premarket session following an early GO decision announced by the company based on an interim responder analysis in the Phase 3 CAPTIVATE ...

IMforte shows lurbinectedin plus atezolizumab maintenance extends PFS and OS in extensive-stage SCLC, with manageable cytopenias and key patient-selection guidance.

Accelerated review was enabled by the Commissioner’s National Priority Voucher Pilot Program, targeting high unmet need and ...

Professor Günter Höglinger, Lead Investigator of the Mascot trial, said: “Completing randomization of a global Phase 3 trial in MSA is a significant achievement for the field.” He added: “Advancing ...

Detailed price information for Adia Nutrition Inc (ADIA) from The Globe and Mail including charting and trades.

Q4 2026 Earnings Call March 4, 2026 5:00 PM ESTCompany ParticipantsGunnar Hansen - Director of Investor RelationsPeter Gassner ...

The findings suggest clinicians don’t need to be as aggressive in lowering BP in this population, at least early after ...

(NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular ...